Literature DB >> 8101545

Preferential expansion and activation of V beta 5+ CD4+ T cells in murine acquired immunodeficiency syndrome.

L A Selvey1, H C Morse, L G Granger, R J Hodes.   

Abstract

Infection of B6 mice with LP-BM5 MuLV results in a syndrome characterized by progressive and profound immunodeficiency, termed murine acquired immunodeficiency syndrome (MAIDS). In this report we show that preferential expansion and activation of V beta 5+ CD4+ spleen cells occurs early in the course of disease, which then progresses to more widespread polyclonal activation of CD4+ T cells. V beta 5 expansion occurs only on infection with MAIDS-associated MuLV and is not observed after infection with other MuLV. The possible role of V beta 5 activation and expansion as a necessary early step in the pathogenesis of MAIDS is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101545

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  T-cell-receptor dose and the time of treatment during murine retrovirus infection for maintenance of immune function.

Authors:  B Liang; S Ardestani; J J Marchalonis; R R Watson
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 2.  Study of the T cell receptor repertoire in viral immunodeficiency disease.

Authors:  C Ciurli; R P Sékaly; H Soudeyns
Journal:  Springer Semin Immunopathol       Date:  1996

Review 3.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Induction of intestinal lesions in nu/nu mice induced by transfer of lymphocytes from syngeneic mice infected with murine retrovirus.

Authors:  K Suzuki; T Narita; R Yui; K Ohtsuka; S Inada; T Kimura; Y Okada; M Makino; T Mizuochi; H Asakura; M Fujiwara
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

5.  Endogenous Mtv-encoded superantigens are not required for development of murine AIDS.

Authors:  T C McCarty; S K Chattopadhyay; M T Scherer; T N Fredrickson; J W Hartley; H C Morse
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.

Authors:  B C Cho; J D Shaughnessy; D A Largaespada; H G Bedigian; A M Buchberg; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 7.  Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice.

Authors:  H C Morse; N Giese; R Morawetz; Y Tang; R Gazzinelli; W K Kim; S Chattopadhyay; J W Hartley
Journal:  Springer Semin Immunopathol       Date:  1995

8.  Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.

Authors:  K A Green; K M Crassi; J D Laman; A Schoneveld; R R Strawbridge; T M Foy; R J Noelle; W R Green
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Evidence that the murine AIDS defective virus does not encode a superantigen.

Authors:  L Doyon; C Simard; R P Sékaly; P Jolicoeur
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Myristylation of Pr60gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells.

Authors:  M Huang; P Jolicoeur
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.